Skip to main content

Table 5 Median haemoglobin concentration (g/dl) of study population during follow-up days at Hamusit Health Centre, Northwest Ethiopia, 2021

From: Therapeutic efficacy of pyronaridine-artesunate (Pyramax®) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia

Variables

Follow up days

Day 0

Day 14

Day 28

Day 42

Median Hb±SD (g/dl)

14.2±2.03

12.7±1.75

13.4±1.52

13.5±1.79

Anaemia status

Mild n (%)

Male

14 (21.2)

27 (40.9)

20 (30.3)

18 (27.3)

Female

0 (0)

3 (15)

4 (20)

2 (10)

Total

14 (21.2)

30 (55.9)

24 (50.3)

20 (37.3)

Moderate (%)

Male

3 (4.5)

12 (18.2)

6 (9.1)

5 (7.5)

Female

2 (10)

2 (10)

0 (0)

0 (0)

Total

5 (15.5)

14 (18.2)

6 (9.1)

5 (7.5)

Total (%)

19 (22.1)

44 (51.2)

30 (34.9)

25 (29.1)